Suppression of thrombocyte aggregation

Details Suppression of thrombocyte aggregation Suppression of thrombocyte aggregation

A - Human Necessities

61

K

167/235

A61K 31/42 (2006.01)

Patent

CA 1063939

ABSTRACT OF THE DISCLOSURE 2-(4,5-bis-p-chlorophenyloxazol-2-yl-mercapto)-propionic acid and its physiologically acceptable salts in the form of an admixture with acetylsalicylic acid or a physiologically acceptable salt thereof is useful for suppressing aggregation of thrombocytes, particularly when administered in a mole ratio of the acetylsalicylic acid to the priopionic acid derivative of 60:1 to 0.1:1. This is useful especially in humans, e.g. for prophylaxis and therapy in cases involving risk of arterial or venous thrombosis.

265049

Affiliated with

Also associated with

Rating

Suppression of thrombocyte aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppression of thrombocyte aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of thrombocyte aggregation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-945123